2025 Q4
2025-11-20
Walmart to Voluntarily Withdraw Listing of Common Stock and Company Notes from NYSE and Transfer Listings to Nasdaq
Listing transfer expected to be completed on December 8, 2025 (NYSE) and December 9, 2025 (Nasdaq)
View Filing →
2025-11-14
CEO C. Douglas McMillon Retires, John R. Furner Appointed as President and CEO
January 31, 2026 (McMillon's retirement date)
View Filing →
2025-10-22
Controller Appointed
Dwayne Milum appointed SVP & Controller, $600K salary
View Filing →
2025 Q3
2025-09-22
Executive 10b5-1 Trading Plan
Chief People Officer plans to sell max 148,665 shares starting Jan 2026
View Filing →
2025-09-19
Executive 10b5-1 Trading Plan
Daniel Danker to sell max 109,976 shares via automated plan
View Filing →
2025-09-05
CFO 10b5-1 Trading Plan
CFO Rainey to sell 40,000 shares in Feb-Mar 2026
View Filing →
2025-08-21
Q2 Earnings
Results for three and six months ended July 31, 2025
View Filing →
2025 Q2
2025-06-06
Annual Shareholder Meeting
91.36% turnout, all 12 directors elected, 7 shareholder proposals rejected
View Filing →
2025-05-15
Q1 Earnings + HQ Relocation
Q1 2025 results for quarter ended April 30, HQ moved to 1 Customer Drive
View Filing →
2025-04-28
Debt Offering
$4B notes issued: Floating rate 2027, 4.1% 2027, 4.35% 2030, 4.9% 2035
View Filing →
2025-04-09
Investment Community Meetings
Press release issued for investor meetings
View Filing →
2025 Q1
2025-03-17
CEO 10b5-1 Trading Plan
McMillon to sell 233,000 shares Jun 2025-May 2026
View Filing →
2025-03-17
John Furner 10b5-1 Trading Plan
157,500 shares max sale over 12 months
View Filing →
2025-02-20
Q4 FY2025 Earnings
Results for Q4 and fiscal year ended January 31, 2025
View Filing →
2024 Q4
2024-11-22
Executive 10b5-1 Trading Plan
Kathryn McLay to sell 40,000 shares over 10 months
View Filing →
2024-11-19
Q3 Earnings
Results for three and nine months ended October 31, 2024
View Filing →
2024-10-18
Opioid Derivative Lawsuit Settlement
$123M insurance payout to settle opioid-related shareholder derivative claims
View Filing →
2024 Q3
2024-09-06
CFO 10b5-1 Trading Plan
CFO Rainey to sell max 95,800 shares through Dec 2025
View Filing →
2024-08-15
Director Appointed
Robert E. Moritz Jr. appointed to Board
View Filing →
2024-08-15
Q2 2024 Earnings
Results for three and six months ended July 31, 2024
View Filing →
2024 Q2
2024-06-07
Annual Shareholder Meeting
91% attendance, all 11 directors elected, executive comp approved
View Filing →
2024-05-16
Q1 2024 Earnings
Results for three months ended April 30, 2024
View Filing →
2024 Q1